Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypertension, Grade 2”

102 trials

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT02072330
What this trial is testing

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Who this might be right for
Grade I or II Essential Hypertension
Takeda 353
Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Large-scale testing (Phase 3)Study completedNCT00430508
What this trial is testing

Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 972
Not applicableLooking for participantsNCT06057051
What this trial is testing

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Who this might be right for
Glaucoma
Glaukos Corporation 245
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Post-approval studies (Phase 4)UnknownNCT02641821
What this trial is testing

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Who this might be right for
Hypertension
Peking University First Hospital 700
Not applicableStudy completedNCT00638911
What this trial is testing

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 33,247
Large-scale testing (Phase 3)Study completedNCT00818883
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

Who this might be right for
Essential Hypertension
Takeda 609
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Post-approval studies (Phase 4)Study completedNCT00147563
What this trial is testing

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

Who this might be right for
Hypertension
Pfizer 34
Post-approval studies (Phase 4)UnknownNCT00716950
What this trial is testing

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Who this might be right for
Essential Hypertension
University of Pavia 187
Post-approval studies (Phase 4)Study completedNCT02006693
What this trial is testing

Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

Who this might be right for
Primary Open Angle Glaucoma
AqueSys, Inc. 199
Post-approval studies (Phase 4)Study completedNCT00654875
What this trial is testing

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

Who this might be right for
Essential Hypertension
Novartis 328
Testing effectiveness (Phase 2)Study completedNCT00046319
What this trial is testing

Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 60
Large-scale testing (Phase 3)Study completedNCT00262236
What this trial is testing

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Novartis 693
Large-scale testing (Phase 3)Study completedNCT00367094
What this trial is testing

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 296
Post-approval studies (Phase 4)UnknownNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Large-scale testing (Phase 3)Study completedNCT01788358
What this trial is testing

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

Who this might be right for
Hypertension
Bayer 508
Large-scale testing (Phase 3)Study completedNCT00430950
What this trial is testing

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 1,011
Testing effectiveness (Phase 2)Study completedNCT01303783
What this trial is testing

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Bayer 1,381
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation